Skip to main content

Tata Memorial Hospital to begin 10-yr long pan India study of aspirin in preventing cancer relapses

The Tata Memorial Hospital (TMH) is all set to start a 10-year long pan India clinical study in a month’s time to determine the efficacy of Aspirin in preventing the risk of cancer relapses.
The study titled “Add- Aspirin” is a joint initiative of TMH and the UK-based Medical Research Council involving 60 Indian investigators and 300 investigators from the UK. TMH recently received clinical trial approval from Ethics Committee of ICMR.

Disclaimer: This information is for educational purposes only, It is not to diagnose or treat your disease. If you do use the information contained on this web site without the approval of a health professional, you are prescribing for yourself, which is your constitutional right, but the author(s) and webmaster assume no responsibility

© 2023 Esophageal Cancer Education Foundation- by domino